logo

Verve Therapeutics Inc (VERV) Stock: Exploring a Year of Highs, Lows, and Trading Volume

OPEN Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Verve Therapeutics Inc’s current trading price is -59.54% away from its 52-week high, while its distance from the 52-week low is 34.03%. The stock’s price range over this period has fluctuated between $4.30 and $14.26. The company, operating within the financial sector, had a trading volume of approximately 1.02 million for the day, which was noticeably lower than the average daily share volume of 1.53 million over the last 3 months.

Verve Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $14.26 on 03/21/24, while the lowest price for the same period was registered at $4.30 on 08/14/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Verve Therapeutics Inc (VERV) has experienced a quarterly decline of -7.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 512.35M and boasts a workforce of 274 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.38, with a change in price of +0.22. Similarly, Verve Therapeutics Inc recorded 1,546,866 in trading volume during the last 100 days, posting a change of +3.96%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VERV stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.12.

VERV Stock Stochastic Average

Today’s raw stochastic average for Verve Therapeutics Inc over the last 50 days is 14.12%.This indicates a increase from the raw stochastic average of the past 20 days, which was 6.78%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 12.52% and 14.76%, respectively.

VERV Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 2.30%.However, over the last six months, we can see a weaker performance of 4.91%. Over the last 30 days, the price of VERV has leaped by -32.75%. And in the last five days, it has fallen by -6.33%.

Most Popular